-
Product Insights
![]()
Net Present Value Model: Oxycontin
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Oxycontin Drug Details Oxycodone hydrochloride (OxyContin,...
-
Sector Analysis
![]()
Bipolar Disorder – Global Drug Forecast and Market Analysis to 2030
GlobalData estimated that drug sales for bipolar disorder in 2020 was valued at $4.1 billion across the eight major markets (8MM) - the US, the five major European markets (5EU) (France, Germany, Italy, Spain, and the UK), Japan, and Canada. It is anticipated that the bipolar disorder market will grow at a compound annual growth rate (CAGR) of more than 1.5% during the forecast period of 2021-2030. The US market makes up the majority of total global sales, contributing to...
-
Product Insights
![]()
Premenstrual Syndrome Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Premenstrual Syndrome Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Premenstrual Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Premenstrual Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
![]()
Herpes Labialis (Oral Herpes) Disease – Global Clinical Trials Review, H2 2020
GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Herpes Labialis (Oral Herpes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Product Insights
![]()
Homozygous Familial Hypercholesterolemia (HoFH) Disease – Global Clinical Trials Review, H2 2020
GlobalData's clinical trial report, “Homozygous Familial Hypercholesterolemia (HoFH) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Homozygous Familial Hypercholesterolemia (HoFH) Clinical trials scenario. This report provides top line data relating to the clinical trials on Homozygous Familial Hypercholesterolemia (HoFH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Product Insights
![]()
Premenstrual Syndrome Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Premenstrual Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Premenstrual Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Premenstrual Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
![]()
Chronic Obstructive Pulmonary Disease – Global Drug Forecast and Market Analysis to 2028
Chronic obstructive pulmonary disease (COPD) is a common, preventable, incurable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation. Long-term exposure to noxious particles or gases such as cigarette smoke and environmental pollution can induce chronic inflammation in the airways, subsequently causing alveolar abnormalities. Pro-inflammatory cytokines, which are secreted from immune cells such as neutrophils, macrophages, and B cells, and CD4+ and CD8+ T lymphocyte infiltration in the lungs, in addition to elastases, can cause destruction...
-
Sector Analysis
![]()
Consumer and Market Insights: Oral Hygiene in Sweden
Oral Hygiene market in Sweden will register marginally higher growth in value terms during 2015-2020 compared to 2010-2015. The Toothpaste category has the highest volume share and is the leading value category in 2015. The Flossing Tape segment is forecast to register maximum gain in market share within Dental Floss category. Screw Top is the most commonly used closure type in Sweden's Oral Hygiene market.
-
Product Insights
![]()
Rosacea Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, H2, 2016" provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Track & Monitor
![]()
PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2018 Edition
This report is the 8th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs.
-
Product Insights
![]()
Cryptococcal Meningitis Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H1, 2019" provides an overview of Cryptococcal Meningitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcal Meningitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
![]()
Cryptococcosis Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, H1, 2019" provides an overview of Cryptococcosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
![]()
Histoplasmosis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Histoplasmosis Global Clinical Trials Review, H2, 2017" provides an overview of Histoplasmosis clinical trials scenario. This report provides top line data relating to the clinical trials on Histoplasmosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
![]()
PharmaPoint: Macular Edema – Global Drug Forecast and Market Analysis to 2026
ME is a condition characterized by the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. The occurrence of ME is highly frequent in diabetics and usually manifests itself as DME, a complication of diabetic retinopathy, and is the most common cause of vision loss in patients affected by diabetes mellitus. In addition the risk for ME is also higher in patients with retinal vein occlusion, a common condition...
-
Product Insights
![]()
Cryptococcal Meningitis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2017" provides an overview of Cryptococcal Meningitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcal Meningitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
![]()
Cryptococcosis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, H2, 2017" provides an overview of Cryptococcosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
![]()
Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H2, 2017" provides an overview of Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Dysbetalipoproteinemia (Type III Hyperlipoproteinemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
![]()
Primary Dysmenorrhea Disease – Global Clinical Trials Review, H2 2019
GlobalData's clinical trial report, “Primary Dysmenorrhea Global Clinical Trials Review, H2, 2019" provides an overview of Primary Dysmenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Dysmenorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
![]()
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H1, 2020" provides an overview of Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by...
-
Sector Analysis
![]()
Dermatophytic Onychomycosis – United States of America (USA) Drug Forecast and Market Analysis to 2028
Onychomycosis (tinea unguium) of the toenail is a fungal infection of the nail by dermatophytic, nondermatophytic, or yeast species. Infection can occur in the nail matrix, nail bed, or nail plate. While dermatophytic onychomycosis (DO) is not considered life-threatening, it can cause discomfort, pain, and physical and occupational limitations. Onychomycosis patients can be identified as having thick or brittle nails, along with discoloration (white and opaque) and inflammation of the skin underneath the nail. GlobalData estimates that sales of drugs...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.